Page 1 of 1

Cladribine cleared for review

Posted: Mon Jul 18, 2016 3:04 am
by MSUK
Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of the investigational product Cladribine for the treatment of relapsing-remitting multiple sclerosis (MS)...Read more - http://www.ms-uk.org/MSnews

Re: Cladribine cleared for review

Posted: Fri Aug 19, 2016 7:38 am
by frodo
MSUK wrote:Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of the investigational product Cladribine for the treatment of relapsing-remitting multiple sclerosis (MS)...Read more - http://www.ms-uk.org/MSnews
Thanks. Good news for everybody following the pipeline. Some people will benefit directly and the rest will benefit from the information collected.